Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
GLP-1 agonists have been shown to diminish the hedonic effects of food in dysregulated individuals, promoting homeostatic eating and influencing food choices toward more nutritious options [6, 7, 16]
The mean dosage of Liraglutide in these studies ranged from 0.78 mg to 3 mg daily, with an average dose of 1.75 mg daily
GLP-1R agonists show promise in weight management however, challenges remain in enhancing their stability and effectiveness in the clinical setting due to natural degradation processes [79, 80]
[9] It is important to emphasise that using GLP-1 receptor agonists specifically to treat NAFLD is currently off-label in the UK
Most adults with a BMI over 27 and weight-related health conditions, or a BMI over 30, may qualify for GLP therapy
Where ever you are finding yourself, I want you to remember that obesity is a disease, one you deserve comprehensive treatment for
US$ 25.89
US$ 26.98
US$ 23.58
US$ 29.78
US$ 27.16
US$ 20.12
US$ 28.74
